Document is current
Any future updates will be listed below
-
Authors
Bettcher, Brianne M.
de Oliveira, Fabricio Ferreira
Willette, Auriel A.
Michalowska, Malgorzata M.
Machado, Luiza Santos
Rajbanshi, Binita
Borelli, Wyllians V.
Tansey, Malú Gámez
Rocha, Andréia
Suryadevara, Vidyani
Hu, William T.
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01 AG058772)
FAPESP - The State of São Paulo Research Foundation (#2015/10109-5)
National Institute of Health (R00 AG047282; R01 MH126979; R21 EB034184, R01 AG054046, RF1 AG054991, R01 AG066203, RF1 AG079251)
Alzheimer's Association (AARFD-24-1307665)
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 31 March 2025
First Online: 15 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: MGT is co-inventor of Xencor’s XPro1595, a soluble TNF-specific biologic under clinical development by INmune Bio for neurological indications. MGT is a consultant/advisor INmune Bio, Merck, Cellestial Therapeutics, Forward Therapeutics, Jaya, NysnoBio Longevity Biotech, Longeveron, iMetabolic Pharm, NovoNordisk, IMMvention, Ventus. MGT has served as an advisor/member on the Medical and Scientific Advisory Group of the Alzheimer’s Association, Weston Family Foundation of Canada, Parkinson’s Foundation, Parkinson’s UK, World Parkinson Coalition, MJ Fox Foundation for Parkinson’s Research, and the Alzheimer’s Disease Cooperative Study Intervention Selection Committee (ADCS-ISC), and the International Linked Clinical Trials (iLCT) of the Cure Parkinson’s Trust. MGT has served on grant review panels for NIH, MF Fox Foundation, Weston Family Foundation, Alzheimer’s Association, Bright Focus Foundation, Alzheimer’s Drug Discovery Foundation (ADDF), Parkinson’s UK. MGT has served as Editor-in-Chief for Nature Partner Journal Parkinson’s Disease, Associate Editor for Science Advances, Alzheimer’s & Dementia: Translational Research and Clinical Interventions (AE), and Journal of Neuroinflammation. WTH has received research support from NIH, Robert Wood Johnson Foundation, Fujirebio Diagnostics Inc, Atlanta Family Foundation, and TMCity Foundation; has consulted for Apellis Pharmaceuticals, Beckman Coulter Diagnostics, Biogen, Fujirebio Diagnostics Inc; has patents on CSF-based diagnosis of FTLD-TDP, prognosis of MCI due to AD, and prognosis of spinal muscular atrophy on gene therapy; and has copyright on Mandarin-based cognitive assessments (licensed to Linus Health).
